NEW YORK (GenomeWeb) – OpGen announced today that it has closed its previously announced public offering, raising $12 million in gross proceeds.

The offering comprised about 2.8 million units at $3.25 per unit, and 851,155 pre-funded units at $3.24 per-refunded unit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.